We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Price loading...
Humana Biomarkers in Breast Cancer (Cancer Drug Discovery and Development)
Price data last checked 103 day(s) ago - refreshing...
Price History & Forecast
No Price Data Available
Price history will appear here once data is collected from Amazon.
Price Distribution
No price data available for histogram
Description
Product Description Expert laboratory and clinical researchers from around the world review how to design and evaluate studies of tumor markers and examine their use in breast cancer patients. The authors cover both the major advances in sophisticated molecular methods and the state-of-the-art in conventional prognostic and predictive indicators. Among the topics discussed are the relevance of rigorous study design and guidelines for the validation studies of new biomarkers, gene expression profiling by tissue microarrays, adjuvant systemic therapy, and the use of estrogen, progesterone, and epidermal growth factor receptors as both prognostic and predictive indicators. Highlights include the evaluation of HER2 and EGFR family members, of p53, and of UPA/PAI-1; the detection of rare cells in blood and marrow; and the detection and analysis of soluble, circulating markers. From the Back Cover It is now well recognized that individualized cancer treatment planning, based on tumor characteristics specific to an individual's cancer, makes it easier to select those most likely to benefit from toxic cancer therapies and to avoid treating those least likely to benefit. In Biomarkers in Breast Cancer: Molecular Diagnostics for Predicting and Monitoring Therapeutic Effect, expert laboratory and clinical researchers from around the world review how to design and evaluate studies of tumor markers, as well as examine their use in breast cancer patients. The authors cover both the major advances in sophisticated molecular methods and the state-of-the-art in conventional prognostic and predictive indicators. Among the topics discussed are the relevance of rigorous study design and guidelines to the validation of new biomarkers, gene expression profiling by tissue microarrays, adjuvant systemic therapy, and the use of estrogen, progesterone, and epidermal growth factor receptors as both prognostic and predictive indicators. Highlights include the evaluation of HER2 and EGFR family members, of p53, and of UPA/PAI-1; the detection of rare cells in blood and marrow; and the detection and analysis of soluble, circulating markers. Authoritative and cutting-edge, Biomarkers in Breast Cancer: Molecular Diagnostics for Predicting and Monitoring Therapeutic Effect offers laboratory investigators developing new tumor markers, clinical investigators testing them, and clinicians using them an up-to-date understanding of both the prognostic/predictive indicators and the novel molecular-targeted therapies suitable for individualizing breast cancer therapy.
Product Specifications
- Brand
- Humana
- Format
- paperback
- ASIN
- 1617374369
- Domain
- Amazon UK
- Release Date
- 01 December 2010
- Listed Since
- 11 July 2010
Barcode
No barcode data available
Similar Products You Might Like
98% match
Biomarkers in Breast Cancer (Cancer Drug Discovery and Development)
Humana
£34.06
12 Jan 2026
95% match
Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis
CRC Press
£103.58
17 Feb 2026
95% match
Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis
CRC Press
£146.42
12 Jan 2026
95% match
Breast Cancer: Molecular Genetics, Pathogenesis, and Therapeutics (Contemporary Cancer Research)
Humana
£162.59
10 Mar 2026
94% match
Translational Research in Breast Cancer: Biomarker Diagnosis, Targeted Therapies and Approaches to Precision Medicine: 1026 (Advances in Experimental Medicine and Biology, 1026)
Springer
£110.00
09 Mar 2026
94% match
Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma (Current Clinical Pathology)
Humana
£64.90
29 Mar 2026
94% match
Breast Cancer: Methods and Protocols: 1406 (Methods in Molecular Biology, 1406)
Humana
£79.50
01 Mar 2026
94% match
Humana Tumor Biomarker Discovery: Methods and Protocols 520
Humana
£102.16
20 Apr 2026
94% match
Research on New Generation Tumor Markers - Nova Science Publishers
£105.35
18 Apr 2026
94% match
Diagnostic, Prognostic and Therapeutic Value of Gene Signatures: 0 (Current Clinical Pathology)
Humana
£80.39
16 Apr 2026
94% match
Molecular Biomarkers for Cancer Diagnosis and Therapy
Springer
£121.71
29 Jan 2026
94% match
Cancer Chemoprevention: Volume 2: Strategies for Cancer Chemoprevention (Cancer Drug Discovery and Development)
Humana
£219.73
09 Apr 2026
94% match
Biomarkers for Immunotherapy of Cancer: Methods and Protocols: 2055 (Methods in Molecular Biology, 2055)
Humana
£110.83
07 Mar 2026
94% match
Biomarkers for Immunotherapy of Cancer: Methods and Protocols: 2055 (Methods in Molecular Biology, 2055)
Humana
£149.00
07 Jan 2026
94% match
Molecular Pathology of Breast Cancer
Springer
£114.75
25 Jan 2026
94% match
Humana The Handbook of Biomarkers - Second Edition
Humana
£154.75
18 Apr 2026
94% match
Humana PI3K-mTOR in Cancer and Cancer Therapy Book
Humana
£109.96
02 Mar 2026
94% match
Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma (Current Clinical Pathology)
Humana
£155.65
24 Jan 2026
94% match
Techniques and Methodological Approaches in Breast Cancer Research
Springer
£110.73
30 Jan 2026
94% match
Cancer Biomarkers in Diagnosis and Therapeutics
£118.00
13 Jan 2026
94% match
Advances in Cancer Biomarkers: From biochemistry to clinic for a critical revision: 867 (Advances in Experimental Medicine and Biology, 867)
Springer
£84.49
22 Feb 2026
94% match
Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development)
Humana
£80.09
28 Feb 2026
94% match
Omics Approaches in Breast Cancer: Towards Next-Generation Diagnosis, Prognosis and Therapy
Springer
£55.39
27 Feb 2026
94% match
Methods of Cancer Diagnosis, Therapy and Prognosis: Breast Carcinoma: 1
Springer
£212.92
14 Jan 2026